Gene Transfer Therapy of Gaucher Disease

Transfusion and Apheresis Science

Volumn 17, Issue 1, 1996, Pages 45-52

  Clarke, J T R ^a   Mahuran, D ^a   Callahan, J W ^a,b   Thorner, P ^b  

^a Research Institute   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347245121     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Beutler E, Grabowski, GA: Gaucher disease, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York, McGraw-Hill Inc., 1995, pp. 2641-2670.
2. Beutler E: Gaucher's disease. N Engl J Med 1991; 325:1354-1360.
3. Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, et al.: Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher disease. N Engl J Med 1991; 324:1464-1470.
4. Barton NW, Brady RO, Dambrosia JM, Doppelt SH, Hill SC, Holder CA, et al.: Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. J Pediatr 1992; 120:277-280.
5. Fallet S, Grace ME, Sibille A, Mendelson DS, Shapiro RS, Hermann G, et al.: Enzyme augmentation in moderate to life-threatening Gaucher disease. Pediatr Res 1992; 31:496-502.
6. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E: The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 1989; 4:87-96.
7. Latham, TE, Theophilus BDM, Grabowski, GA, Smith FI: Heterogeneity of mutations in the acid β-glucosidase gene of Gaucher disease patients. DNA Cell Biol 1991; 10:15-21.
8. Tsuji S, Martin BM, Barranger JA, Stubblefield BK, LaMarca ME, Ginns EI: Genetic heterogeneity in type I Gaucher disease: multiple genotypes in Ashkenazi and non-Ashkenazi individuals. Proc Natl Acad Sci USA 1988; 85:2349-2352.
9. Beutler E, Gelbart T: Mutation analysis in Gaucher disease. Am J Med Genet 1992; 44:389-389.
10. Horowitz M, Tzuri G, Eyal N, Berebi A, Kolodny EH, Brady RO, et al.: Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am J Human Genet 1993; 53:921-930.
11. Beutler E, Gelbart T: Gaucher disease mutations in non-Jewish patients. Br J Haematol 1993; 85:401-405.
12. Beutler E, Gelbart T, Demina A, Zimran A, LeCoutre P: Five new Gaucher disease mutations. Blood Cells Mol Dis 1995; 21: 20-24.
13. Tybulewicz V, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield J, et al.: Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 1992; 357:407-410.
14. Ohashi T, Boggs S, Robbins P, Bahnson A, Patrene K, Wei F-S, et al.: Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc Natl Acad Sci USA 1992; 89:11332-11336.
15. Xu L, Stahl SK, Dave H, Schiffmann R, Correll PH, Kessler S, et al.: Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol. Exp Hematol 1994; 22:223-230.
16. Robbins PD, Tahara H, Mueller G, Hung G, Bahnson A, Zitvogel L, et al.: Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis. Ann NY Acad Sci 1994; 716:72-89.
17. Krall WJ, Challita PM, Perlmutter LS, Skelton DC, Kohn DB: Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 1994; 83:2737-2748.
18. Karlsson S, Correll PH, Xu L: Gene transfer and bone marrow transplantation with special reference to Gaucher's disease. Bone Marrow Transplant 1993; 11 (suppl 1): 124-127.
19. Nolta JA, Yu XJ, Bahner I, Kohn DB: Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest 1992; 90:342-348.
20. Tolstoshev P: Gene therapy, concepts, current trials and future directions. Annu Rev Pharmacol Toxicol 1993; 32:573-596.
21. Vile RG, Russell SJ: Retroviruses as vectors. Br Med Bull 1995; 51:12-30.
22. McLachlin JR, Cornetta K, Eglitis MA, Anderson WF: Retroviral-mediated gene transfer. Prog Nucl Acid Res Mol Biol 1990; 38:91-135.
23. Correll PH, Colilla S, Dave HPG, Karlsson S: High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood 1992; 80:331-336.
24. Correll PH, Karlsson S: Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells. Eur J Haematol 1994; 53:253-264.
25. Biozzi G, Stiffel C: The physiopathology of the reticuloendothelial cells of the liver and spleen, in Popper H, Schaffner F (eds) Progress in Liver Diseases, Vol. 2. New York, Grune and Stratton, 1965, pp. 166-191.
26. Hodgson CP: The vector void in gene therapy. Biotechnology 1995; 13:222-225.
27. Huitinga I, Damoiseaux JG, van Rooijen N, Dopp EA, Dijkstra CD: Liposome mediated affection of monocytes. Immunobiology 1992; 185:11-19.
28. van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes, and applications. J Immunol Meth 1994; 174:83-93.
29. Kole L, Sakar K, Mahato SB, Das PK: Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis. Biochem Biophys Res Commun 1994; 200:351-358.
30. Cotten M, Wagner E, Zatloukal K, Birnstiel ML: Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol 1993; 67: 3777-3785.
31. Plank C, Obserhauser B, Mechtler K, Koch C, Wagner E: The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994; 269: 12918-12924.
32. Straubinger RM, Düzgünes N, Papahadjopoulos D: pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 1985; 179: 148-154.
33. Farhood H, Gao X, Son K, Yang YY, Lazo JS, Huang L, et al.: Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann NY Acad Sci 1994; 716:23-34.
34. Philip R, Brunette E, Kilinski L, Murugesh D, McNally MA, Ucar K, et al.: Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol 1994; 14:2411-2418.
35. Debs R, Pian M, Gaensler K, Clements J, Friend DS, Dobbs L: Prolonged transgene expression in rodent lung cells. Am J Resp Cell Mol Biol 1992; 7:406-413.
36. Zhu N, Liggitt D, Liu Y, Debs R: Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261:209-211.
37. Philip R, Liggitt D, Philip M, Dazin P, Debs R: In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice. J Biol Chem 1993; 268:16087-16090.
38. Larochelle A, Vormoor J, Lapidot T, Sher G, Furukawa T, Li Q; Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Human Mol Genet 1995; 4:163-172.